chartexchange

Kura Oncology to Participate in Two Investor Conferences in November

GlobeNewswire Inc. | Nov 13, 2026 12:33 PM EST

SAN DIEGO, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company focused on precision medicines for the treatment of cancer, today announced that management will present at the following investor conferences:

Read original article